NCT01985841 - Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Breast Cancer

Interventions

DRUG

Bevacizumb

Avastin

DRUG

5-Fluorouracil

5-FU

DRUG

Epirubicin

Farmorubicin

DRUG

Cyclophosphamide

Endoxan

DRUG

Docetaxel

Taxotere

Trial Locations (6)

"IASO General Hospital of Athens", Athens

Air Forces Military Hospital of Athens, Athens

University Hospital of Crete, Dep of Medical Oncology Heraklion, Greece, Heraklion

"Metaxa's Anticancer Hospital of Piraeus, 1st Dep of Medical Oncology", Piraeus

"Euromedica Hospital of Thessaloniki", Thessaloniki

"Theagenion Anticancer Hospital of Thessaloniki, 2nd Dep of Medical Oncology", Thessaloniki